- Home
- NVTS vs DNA Comparison
NVTS vs DNA Comparison
Compare NVTS & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVTS
- DNA
- Stock Information
- Founded
- NVTS 2014
- DNA 2008
- Country
- NVTS United States
- DNA United States
- Employees
- NVTS N/A
- DNA N/A
- Industry
- NVTS Semiconductors
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NVTS Technology
- DNA Health Care
- Exchange
- NVTS Nasdaq
- DNA Nasdaq
- Market Cap
- NVTS 473.3M
- DNA 423.5M
- IPO Year
- NVTS N/A
- DNA N/A
- Fundamental
- Price
- NVTS $1.78
- DNA $6.37
- Analyst Decision
- NVTS Buy
- DNA Hold
- Analyst Count
- NVTS 8
- DNA 6
- Target Price
- NVTS $4.75
- DNA $37.80
- AVG Volume (30 Days)
- NVTS 3.3M
- DNA 1.2M
- Earning Date
- NVTS 11-04-2024
- DNA 11-12-2024
- Dividend Yield
- NVTS N/A
- DNA N/A
- EPS Growth
- NVTS N/A
- DNA N/A
- EPS
- NVTS N/A
- DNA N/A
- Revenue
- NVTS $91,381,000.00
- DNA $217,951,000.00
- Revenue This Year
- NVTS $8.34
- DNA N/A
- Revenue Next Year
- NVTS $5.50
- DNA $12.85
- P/E Ratio
- NVTS N/A
- DNA N/A
- Revenue Growth
- NVTS 38.99
- DNA N/A
- 52 Week Low
- NVTS $1.76
- DNA $5.26
- 52 Week High
- NVTS $8.44
- DNA $75.20
- Technical
- Relative Strength Index (RSI)
- NVTS 30.33
- DNA 33.79
- Support Level
- NVTS $1.77
- DNA $8.13
- Resistance Level
- NVTS $1.93
- DNA $10.07
- Average True Range (ATR)
- NVTS 0.17
- DNA 0.70
- MACD
- NVTS -0.08
- DNA -0.14
- Stochastic Oscillator
- NVTS 1.75
- DNA 8.87
About NVTS Navitas Semiconductor Corporation
Navitas Semiconductor Corp develops ultra-efficient gallium nitride (GaN) semiconductors that are revolutionizing power electronics. GaN power ICs integrate GaN power with drive, control, and protection to enable fast charging, high power density, and energy savings for mobile, consumer, enterprise, eMobility, and new energy markets. The company operates as one reportable segment, the design, development, manufacture, and marketing of integrated circuits and related components for use in mobile device and other markets. Geographically, the company operates in China, Europe, United States, Rest of Asia and Others. The majority of revenue is generated from China.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.